| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3332169 | Hematology/Oncology Clinics of North America | 2007 | 16 Pages |
Abstract
Blood transfusion utilization continues to rise, yet it has never undergone prospective safety and efficacy testing. Recent data regarding oxygen delivery, microcirculation, and inflammation all point toward potential problems with allogeneic transfusion. Outcome data from retrospective data bases are sobering, calling to question the present practices of red cell transfusion.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Bruce D. Spiess,